Shares of Veradigm, a company that helps healthcare providers use data and technology, are going down because they said their earnings for this year will be lower than what people expected. This is because they didn't get as much money from some legal settlements as they thought they would. Read from source...

- The article is titled in a misleading way, implying that Veradigm shares are trading lower today because of some negative news or event, while the real reason is that they provided below-consensus guidance for FY23. This creates a false impression that there is something wrong with the company or the industry, rather than acknowledging the market's reaction to their performance expectations.
- The article uses vague terms and numbers without explaining what they mean or how they are derived. For example, it says Veradigm shares "drop" but does not specify by how much or in relation to what benchmark. It also mentions a "favorable customer litigation settlement", which is supposed to be positive for the company, but it does not clarify if this is included or excluded from the guidance figures, and how it affects the revenue and EPS projections.
- The article quotes an unnamed analyst who projects some numbers for FY23, without citing their source, credentials, or methodology. This makes the information questionable and unreliable, as well as potentially biased or self-serving. It also creates confusion about whose estimates are being compared to the guidance, since there is no indication of whether they are from Veradigm itself, the analyst firm, or some other third party.
- The article ends with a generic sentence that does not provide any conclusion, insight, or recommendation for investors or readers. It simply repeats what the title already stated, without adding any value or perspective. This leaves the reader feeling unsatisfied and frustrated, as they do not learn anything new or useful from the article.

To answer your question about why Veradigm shares are trading lower today, I would need to access more information than what is available in this article. However, based on the given data, it seems that the company's FY23 guidance is below consensus estimates, which could explain the decline in share price. Additionally, there may be other factors influencing the market sentiment towards Veradigm, such as competitive pressures, regulatory changes, or industry trends. To provide more accurate and comprehensive investment recommendations, I would need to analyze the company's financial statements, key metrics, valuation, growth prospects, and risks. Furthermore, I would also need to consider the broader market context, such as interest rates, inflation, geopolitical events, and investor sentiment. All of these factors could impact the performance of Veradigm's shares in the short-term or long-term. Therefore, my advice is that you should do your own research and consult with a professional financial advisor before making any investment decisions based on this article.